Core Scientific, Inc. Form 8-K Summary
Business context and reporting period
Core Scientific, Inc. filed a Form 8-K reporting events occurring on October 26, 2022. The filing primarily addresses a board appointment and significant deterioration in operating performance and liquidity. It does not provide quarterly revenue, profit, margin, or cash-flow results.
Key financial and operating metrics
| Metric | Reported value |
|---|---|
| Bitcoin holdings at October 26, 2022 | 24 bitcoins |
| Bitcoin holdings at September 30, 2022 | 1,051 bitcoins |
| Cash at October 26, 2022 | Approximately $26.6 million |
| Cash at September 30, 2022 | Approximately $29.5 million |
| Shares sold under B. Riley equity line | 13,354,892 shares |
| Net proceeds from B. Riley equity line | Approximately $20.7 million |
| Remaining equity-line capacity | Up to $100 million in total, subject to limitations and conditions; the filing does not state remaining availability |
| New director compensation | $35,000 monthly fee for Neal P. Goldman |
Management attributed pressure on operating performance and liquidity to the prolonged decline in bitcoin prices, higher electricity costs, increased global bitcoin network hash rate, and litigation involving Celsius Networks and its affiliates.
Material changes versus the prior comparable period
- Bitcoin holdings declined by 1,027 bitcoins, from 1,051 at September 30 to 24 at October 26, 2022.
- Cash declined by approximately $2.9 million, from $29.5 million to $26.6 million over the same period.
- The Board increased from six to seven members following the appointment of Neal P. Goldman.
- The Company decided not to make payments due in late October and early November 2022 on several equipment and other financings, including two bridge promissory notes.
- The Company had sold 13,354,892 shares under its B. Riley equity line for approximately $20.7 million of net proceeds, creating dilution for existing shareholders.
Outlook, risks, contingencies, and unusual items
- Creditors may exercise remedies after applicable grace periods, including accelerating debt, suing for nonpayment, or taking action against collateral.
- Defaults under these facilities could trigger events of default under other indebtedness, including two series of convertible notes due 2025.
- The Company engaged Weil, Gotshal & Manges LLP as legal adviser and PJT Partners LP as financial adviser to evaluate strategic alternatives and liquidity initiatives.
- Potential alternatives include additional equity or debt financing, liability-management transactions, debt exchanges for equity or additional debt, delayed capital expenditures, asset sales, and potential bankruptcy or insolvency proceedings.
- Debt-for-equity transactions and further use of the B. Riley equity line could materially dilute common shareholders.
- Management expected existing cash resources to be depleted by the end of 2022 or sooner, depending on operating revenue and other assumptions.
- The filing states that substantial doubt exists about the Company’s ability to continue as a going concern for a reasonable period.
- Key continuing risks include bitcoin-price volatility, energy costs, network hash-rate changes, creditor actions, Celsius-related litigation, Nasdaq listing compliance, access to capital, and possible restructuring or bankruptcy.
Board appointment
Neal P. Goldman was appointed to the Board on October 26, 2022. The Company expected to enter into a customary indemnification agreement with him. The filing reports no related-party transaction requiring disclosure, no family relationship with existing directors or officers, and no arrangement under which he was selected.
Important facts for investors to verify
- Whether the Company made or failed to cure the identified debt payments and whether creditors declared defaults or accelerated obligations.
- The remaining availability and terms of the B. Riley equity line, including additional share issuance and dilution.
- Actual cash usage, bitcoin sales or transfers, operating revenue, and liquidity after October 26, 2022.
- The status and outcome of negotiations with creditors and advisers regarding refinancing, restructuring, asset sales, or other strategic alternatives.
- Whether the Company entered bankruptcy, insolvency, or another formal restructuring process.
- The financial impact and legal status of the Celsius litigation.
- Whether the Company maintained its Nasdaq listing and complied with covenants in its other debt agreements.